0000899243-22-008178.txt : 20220228
0000899243-22-008178.hdr.sgml : 20220228
20220228191051
ACCESSION NUMBER: 0000899243-22-008178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220224
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Snodgres Jon
CENTRAL INDEX KEY: 0001613498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 22692853
MAIL ADDRESS:
STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET
STREET 2: BUILDING #1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02435
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-24
0
0000730272
REPLIGEN CORP
RGEN
0001613498
Snodgres Jon
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
Chief Financial Officer
Common Stock
2022-02-24
4
A
0
3443
0.00
A
33904
D
Common Stock
2022-02-24
4
F
0
269
189.21
D
33635
D
Stock Option (Right to Buy)
189.21
2022-02-24
4
A
0
4410
0.00
A
2032-02-24
Common Stock
4410
4410
D
Mr. Snodgres was awarded 3,443 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
One third of the stock options will vest and become exercisable annually on February 24, 2023, February 24, 2024 and February 24, 2025.
/s/ Kimberly Brown (Attorney in Fact)
2022-02-28